Efficacy of Starting Methotrexate Early in Chikungunya Arthritis
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
This is a single center, prospective, randomized controlled open label trial with a one sided
cross over design to compare the efficacy of initiating Methotrexate(Mtx) in early post
Chikungunya induced arthritis (4-12 weeks after onset) with Non Steroidal Anti inflammatory
Drugs(NSAID) alone.
Phase:
N/A
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research